Cargando…

Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes

BACKGROUND: Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC (RVVC) are largely outdated. The purpose of this study was to obtain current patient perspectives of several aspects of VVC/RVVC. METHODS: Bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yano, Junko, Sobel, Jack D., Nyirjesy, Paul, Sobel, Ryan, Williams, Valerie L., Yu, Qingzhao, Noverr, Mairi C., Fidel, Paul L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441174/
https://www.ncbi.nlm.nih.gov/pubmed/30925872
http://dx.doi.org/10.1186/s12905-019-0748-8
_version_ 1783407508563427328
author Yano, Junko
Sobel, Jack D.
Nyirjesy, Paul
Sobel, Ryan
Williams, Valerie L.
Yu, Qingzhao
Noverr, Mairi C.
Fidel, Paul L.
author_facet Yano, Junko
Sobel, Jack D.
Nyirjesy, Paul
Sobel, Ryan
Williams, Valerie L.
Yu, Qingzhao
Noverr, Mairi C.
Fidel, Paul L.
author_sort Yano, Junko
collection PubMed
description BACKGROUND: Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC (RVVC) are largely outdated. The purpose of this study was to obtain current patient perspectives of several aspects of VVC/RVVC. METHODS: Business cards containing on-line survey information were distributed to healthy volunteers and patients seeking standard, elective, or referral gynecologic care in university-affiliated Obstetrics/Gynecology clinics. The internet-based questionnaire was completed by 284 non-pregnant women (78% Caucasian, 14% African American, 8% Asian). RESULTS: The majority of the participants (78%) indicated a history of VVC with 34% defined as having RVVC. The most common signs/symptoms experienced were itching, burning and redness with similar ranking of symptoms among VVC and RVVC patients. Among risk factors, antibiotic use ranked highest followed by intercourse, humid weather and use of feminine hygiene products. A high number of respondents noted ‘no known cause’ (idiopathic episodes) that was surprisingly similar among women with a history of either VVC or RVVC. VVC/RVVC episodes reported were primarily physician-diagnosed (73%) with the remainder mostly reporting self-diagnosis and treating with over-the-counter (OTC) medications. Most physician-diagnosed attacks utilized a combination of pelvic examination and laboratory tests followed by prescribed antifungals. Physician-treated cases achieved a higher level of symptom relief (84%) compared to those who self-medicated (57%). The majority of women with RVVC (71%) required continual or long-term antifungal medication as maintenance therapy to control symptoms. CONCLUSIONS: Current patient perspectives closely reflect historically documented estimates of VVC/RVVC prevalence and trends regarding symptomatology, disease management and post-treatment outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12905-019-0748-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6441174
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64411742019-04-11 Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes Yano, Junko Sobel, Jack D. Nyirjesy, Paul Sobel, Ryan Williams, Valerie L. Yu, Qingzhao Noverr, Mairi C. Fidel, Paul L. BMC Womens Health Research Article BACKGROUND: Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC (RVVC) are largely outdated. The purpose of this study was to obtain current patient perspectives of several aspects of VVC/RVVC. METHODS: Business cards containing on-line survey information were distributed to healthy volunteers and patients seeking standard, elective, or referral gynecologic care in university-affiliated Obstetrics/Gynecology clinics. The internet-based questionnaire was completed by 284 non-pregnant women (78% Caucasian, 14% African American, 8% Asian). RESULTS: The majority of the participants (78%) indicated a history of VVC with 34% defined as having RVVC. The most common signs/symptoms experienced were itching, burning and redness with similar ranking of symptoms among VVC and RVVC patients. Among risk factors, antibiotic use ranked highest followed by intercourse, humid weather and use of feminine hygiene products. A high number of respondents noted ‘no known cause’ (idiopathic episodes) that was surprisingly similar among women with a history of either VVC or RVVC. VVC/RVVC episodes reported were primarily physician-diagnosed (73%) with the remainder mostly reporting self-diagnosis and treating with over-the-counter (OTC) medications. Most physician-diagnosed attacks utilized a combination of pelvic examination and laboratory tests followed by prescribed antifungals. Physician-treated cases achieved a higher level of symptom relief (84%) compared to those who self-medicated (57%). The majority of women with RVVC (71%) required continual or long-term antifungal medication as maintenance therapy to control symptoms. CONCLUSIONS: Current patient perspectives closely reflect historically documented estimates of VVC/RVVC prevalence and trends regarding symptomatology, disease management and post-treatment outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12905-019-0748-8) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-29 /pmc/articles/PMC6441174/ /pubmed/30925872 http://dx.doi.org/10.1186/s12905-019-0748-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Yano, Junko
Sobel, Jack D.
Nyirjesy, Paul
Sobel, Ryan
Williams, Valerie L.
Yu, Qingzhao
Noverr, Mairi C.
Fidel, Paul L.
Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes
title Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes
title_full Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes
title_fullStr Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes
title_full_unstemmed Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes
title_short Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes
title_sort current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441174/
https://www.ncbi.nlm.nih.gov/pubmed/30925872
http://dx.doi.org/10.1186/s12905-019-0748-8
work_keys_str_mv AT yanojunko currentpatientperspectivesofvulvovaginalcandidiasisincidencesymptomsmanagementandposttreatmentoutcomes
AT sobeljackd currentpatientperspectivesofvulvovaginalcandidiasisincidencesymptomsmanagementandposttreatmentoutcomes
AT nyirjesypaul currentpatientperspectivesofvulvovaginalcandidiasisincidencesymptomsmanagementandposttreatmentoutcomes
AT sobelryan currentpatientperspectivesofvulvovaginalcandidiasisincidencesymptomsmanagementandposttreatmentoutcomes
AT williamsvaleriel currentpatientperspectivesofvulvovaginalcandidiasisincidencesymptomsmanagementandposttreatmentoutcomes
AT yuqingzhao currentpatientperspectivesofvulvovaginalcandidiasisincidencesymptomsmanagementandposttreatmentoutcomes
AT noverrmairic currentpatientperspectivesofvulvovaginalcandidiasisincidencesymptomsmanagementandposttreatmentoutcomes
AT fidelpaull currentpatientperspectivesofvulvovaginalcandidiasisincidencesymptomsmanagementandposttreatmentoutcomes